Diasorin products

The LIAISON^® Rubella IgG assay uses chemiluminescence immunoassay (CLIA) technology for the quantitative determination of specific IgG antibodies to rubella virus in human serum or plasma samples. The test has to be performed on the LIAISON^® analyzer family.

The LIAISON^® Measles IgG assay uses chemiluminescence immunoassay (CLIA) technology for the semi-quantitative determination of specific IgG antibodies to measles virus in human serum or plasma samples. It is intended to be used as an aid in the determination of serological status to measles virus. The test has to be performed on the LIAISON^® analyzer family.

The LIAISON^® Mumps IgG assay uses chemiluminescence immunoassay (CLIA) technology for the semi-quantitative determination of specific IgG antibodies to mumps virus in human serum or plasma samples. It is intended to be used as an aid in the determination of serological status to mumps virus. The test has to be performed on the LIAISON^® analyzer family.

The LIAISON^® VZV IgG assay uses chemiluminescence immunoassay (CLIA) technology for the quantitative determination of specific IgG antibodies to varicella-zoster virus (VZV) in human serum or plasma samples. The test has to be performed on the LIAISON^® analyzer family.